AzTrials
AzTrials

Phobia, SocialiSOFIE-RoNCT01557894

Internet Treatment for Social Phobia in Romania

A study testing iSOFIE in people with Phobia, Social, run by Babes-Bolyai University at 1 site in Romania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main aim of this study is to investigate the effectiveness of an Internet-delivered intervention for social phobia by comparing it to a waitlist control group. The second aim of the study is to track the potential changes in participants' thinking patterns. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Phobia, Social
What is being tested?
iSOFIE
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
1 siteRomania
Study dates
Apr 2012to Mar 2013
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • over 18 years
  • social anxiety disorder is the primary diagnostic (according to the DSM-IV)
  • access to an Internet connected computer
  • be fluent in Romanian language

Who cannot join

  • suicidal ideation
  • ongoing psychological treatment for social anxiety disorder
  • recent change in psychiatric medication (i.e., during the last 6 weeks)
  • psychoses or borderline personality disorder

Trial locations and contacts

1 site in 1 country.

Romania1 site
  • Babes-Bolyai University

    Cluj-Napoca, Cluj, 400084

Other trials in Romania

About this study

Official title: Internet Treatment for Social Phobia in Romania: A Randomized Controlled Trial

The main aim of this study is to investigate the effectiveness of an Internet-delivered intervention for social phobia by comparing it to a waitlist control group. The second aim of the study is to track the potential changes in participants' thinking patterns. Because this is among the first guided Internet-delivered interventions conducted in Romania, the treatment credibility will also be investigated. Finally, the predictive power of anxiety sensitivity for both SAD symptoms and the treatment effectiveness will be investigated.

Read the detailed description

The primary aim of this study is to investigate the effectiveness of an internet intervention for social phobia (i.e., the iSOFIE) by comparing it to a waitlist control group. iSOFIE was derived from a previously tested program (Furmark, Holmström, Sparthan, Carlbring, \& Andersson, 2006) and has been significantly shortened while retaining the most important elements. The second aim of the study is to track the potential changes in participants' thinking patterns. While this intervention is primarily based on the cognitive-behavioral model of SAD (Clark and Wells, 1995), and no specific Rational Emotive Behavior Therapy (REBT, Ellis \& Dryden, 1997) will be implemented, it is hypothesized that the cognitive restructuring and exposure exercises will make participants less prone to irrational thinking (as measured by the Attitude and Belief Scale-II (ABS-II, DiGiuseppe, Leaf, Exner, \& Robin, 1988). To our knowledge, no study has investigated whether an iCBT program for SAD has the potential to alter participants' irrational thinking patterns. Moreover, because this is among the first guided Internet-delivered interventions conducted in Romania, the treatment credibility of the program will be investigated. Finally, the predictive power of anxiety sensitivity for both SAD symptoms and the treatment effectiveness will be investigated.

Conditions
Phobia, Social
Being tested
iSOFIE
Keywords
Social anxiety disorders, Social phobia, Anxiety sensitivity, Irrational thinking, Guided self-help, Internet-delivered treatment
Medical subject headings
Phobia, Social

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • iSOFIEOther

    Cognitive - Behavioral: Internet-administrated CBT for social phobia that contains 9 self-help text modules and exercises (i.e., behavioral experiments)

Study groups in NCT01557894
Study groupRoleWhat they receive
iSOFIEExperimentalCognitive - Behavioral: Internet-administrated CBT for Social Phobia that contains 9 self-help text modules and exercises (i.e., behavioral experiments)
Receives: Other: iSOFIE
Waitlist control groupNo interventionWaitlist control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Leibowitz Social Anxiety Scale - Self Report (LSAS-SR)

    The Leibowitz Social Anxiety Scale - Self Report (LSAS-SR) measures social anxiety.

    LSAS-SR presents 24 commonly anxiety-provoking situations, and asks participants to rate their fear and avoidance for each situation.

    In order to obtain the total LSAS-SR score the Anxiety and Avoidance subscales scores are added together.

    The LSAS-SR total score ranges from 0-144, with higher scores corresponding to greater social anxiety

    Measured: pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37)

  2. Social Phobia Inventory (SPIN)

    The Social Phobia Inventory (SPIN) is a brief (i.e., 17-item) self-report instrument measuring fear in social situations, avoidance of performance/social events, and physiological discomfort in social situations. Each item is rated on a 4-point scale.

    Thus, for SPIN the range of scores is 0-68, with higher scores reflecting higher levels of social anxiety symptomatology

    Measured: pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37)

Secondary outcomes (3)
  1. Beck Depression Inventory-II (BDI-II)

    Beck Depression Inventory-II (BDI-II) is a 21-item self-report inventory widely used to assess DSM-IV depressive symptoms. Each item consists of four statements, scored 0-3, indicating increasing symptom severity.

    Thus, for BDI-II the range of scores is 0-63, with higher scores reflecting higher levels of depression.

    Measured: pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37)

  2. Attitude and Belief Scale-II (ABS-II)

    The Attitude and Belief Scale-II (ABS-II) measures rational and irrational thinking as described by Albert Ellis. The scale was designed to capture four cognitive processes (i.e., demandingness, awfulizing, low frustration tolerance, and self-downing/global evaluation) in three content areas (i.e., achievement, approval, and comfort). We selected the 72-item ABS-II because preliminary psychometrics are available for the Romanian population.

    The total ABS-II score range from 0 to 360, with higher scores corresponding to greater irrationality.

    Measured: pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37)

  3. Anxiety Sensitivity Index (ASI)

    The Anxiety Sensitivity Index (ASI) is a 16-item questionnaire that measures the beliefs about the social and somatic consequences of anxiety symptoms. The total ASI score ranges from 0 to 64, with higher scores corresponding to greater anxiety sensitivity.

    Measured: pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2012 (estimated)
  2. Study startApr 2012
  3. Primary completionMar 2013
  4. Study completionMar 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01557894
Sponsor's protocol ID
TTudor
Acronym
iSOFIE-Ro
Status last verified
Sep 2014
First submitted
15 Mar 2012
Last updated
17 Sep 2014
Data monitoring committee
No

Publications

  • Tulbure BT, Mansson KN, Andersson G. Internet treatment for social anxiety disorder in Romania: study protocol for a randomized controlled trial. Trials. 2012 Oct 30;13:202. doi: 10.1186/1745-6215-13-202.

    PubMed 23111108
  • Tulbure BT, Szentagotai A, David O, Stefan S, Mansson KN, David D, Andersson G. Internet-delivered cognitive-behavioral therapy for social anxiety disorder in Romania: a randomized controlled trial. PLoS One. 2015 May 4;10(5):e0123997. doi: 10.1371/journal.pone.0123997. eCollection 2015.

    PubMed 25938241

Questions about this trial

What is this clinical trial studying?

A study testing iSOFIE in people with Phobia, Social, run by Babes-Bolyai University at 1 site in Romania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Sep 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 12 Aug 2014). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Leibowitz Social Anxiety Scale - Self Report (LSAS-SR) (time frame: pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01557894, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in